Hebei Da'an Pharmaceutical

Hebei Da'an Pharmaceutical is a specialized biopharmaceutical company focused on the production of plasma-derived medicinal products (PDMPs). Founded in 2003 and headquartered in Shijiazhuang, China, the company operates a comprehensive facility for plasma fractionation and the manufacture of biological therapeutics. Its core product line includes human albumin, intravenous immunoglobulin (IVIG), and specialized immunoglobulins for Hepatitis B, Tetanus, and Rabies. The company was previously a subsidiary of Walvax Biotechnology before a controlling interest was acquired by Boya Bio-pharmaceutical. Hebei Da'an maintains several plasma collection stations to ensure a stable supply of raw materials for its manufacturing processes. The company is a significant contributor to the Chinese blood products market, adhering to national GMP standards.